Table 2.
Outcome completion rate associated with the recruitment approaches used during the DAD trial
| Original approach | In-clinic approach | Pvalue | |
|---|---|---|---|
|
Patients enrolled, n (% of eligible set) |
48 (40) |
62 (72) |
<0.0001 |
|
Patient survey |
|
|
|
| Patient post-visit survey return rate, n (%)a |
45 (100) |
54 (93) |
0.07 |
| Patient 3-month survey return rate, n (%) |
38 (84) |
38 (66) |
0.03 |
| Patient 6-month survey return rate, n (%) |
32 (71) |
27 (47) |
0.01 |
|
Clinician survey |
|
|
|
| Clinician survey return rate, n (%) |
45 (100) |
50 (86) |
0.01 |
|
Qualitative interview |
|
|
|
| Patients that agreed to qualitative interview, n (%) |
18 (40) |
22 (38) |
0.96 |
|
Encounter video recording |
|
|
|
| Patients that agreed to have the encounter video-recorded, n (%) | 19 (42) | 23 (40) | 0.79 |
aBased on 45 and 58 patients used in analysis, respectively. DAD decision aids for diabetes.